Prevention of Restenosis with Antioxidants: Mechanisms and Implications

Author： Tardif J-C.   Grégoire J.   L'Allier P.L.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.2, Iss.5, 2002-01, pp. : 323-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of restenosis with antioxidants

By  

Inpharma, Vol. 1, Iss. 1358, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Anti-Proliferative Compounds for the Prevention of Restenosis: Anti-Restenotic Mechanisms of Paclitaxel Action

By  

Current Pharmaceutical Design, Vol. 16, Iss. 36, 2010-12 ,pp. : 3989-4001

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological treatment for prevention of restenosis

By Linde Jacek   Strauss Bradley H  

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. : 281-302

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological prevention and management of restenosis

By Tiroch Klaus A   Byrne Robert A   Kastrati Adnan  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1855-1872

Informa Healthcare

Access to resources Recommend Favorite

Novel approaches for the prevention of restenosis

By Gruberg L.   Waksman R.   Satler L.F.   Pichard A.D.   Kent K.M.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2555-2578

Informa Healthcare

Access to resources Recommend Favorite